NewBridge Pharmaceuticals

New Bridge Pharmaceuticals

Pharmaceuticals, 1 Embarcadero CTR, Dubai, California, 94111, United States, 51-200 Employees

nbpharma.com

  • facebook
  • LinkedIn

phone no Phone Number: +12*********

Who is NEWBRIDGE PHARMACEUTICALS

NewBridge Pharmaceuticals is a regional specialty company established to bridge the access gap and partner with pharma & biotech companies to in-license and commercialize FDA or EMA/Europ...

Read More

map
  • 1 Embarcadero CTR, Dubai, California, 94111, United States Headquarters: 1 Embarcadero CTR, Dubai, California, 94111, United States
  • 2010 Date Founded: 2010
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from NEWBRIDGE PHARMACEUTICALS

NewBridge Pharmaceuticals Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding NewBridge Pharmaceuticals

Answer: NewBridge Pharmaceuticals's headquarters are located at 1 Embarcadero CTR, Dubai, California, 94111, United States

Answer: NewBridge Pharmaceuticals's phone number is +12*********

Answer: NewBridge Pharmaceuticals's official website is https://nbpharma.com

Answer: NewBridge Pharmaceuticals's revenue is $25 Million to $50 Million

Answer: NewBridge Pharmaceuticals's SIC: 2834

Answer: NewBridge Pharmaceuticals has 51-200 employees

Answer: NewBridge Pharmaceuticals is in Pharmaceuticals

Answer: NewBridge Pharmaceuticals contact info: Phone number: +12********* Website: https://nbpharma.com

Answer: NewBridge Pharmaceuticals is a regional specialty company established to bridge the access gap and partner with pharma & biotech companies to in-license and commercialize FDA or EMA/European approved innovative pharmaceutics, biologics, & other healthcare solutions in the Middle East and Africa region. The areas of Oncology, Immunology, Neuroscience, Gastrointestinal & Nutrition are NewBridges current strategic focus. The existing product portfolio was built to address unmet medical needs in the region & enabled the company not just to gain substantial presence, but also to help patients gain access to these much-needed innovations. NewBridge is driven by highly experienced leadership in the biopharmaceutical industry regionally & globally, as well as talented motivated teams with a proven track record of regional achievements, which collectively has allowed NewBridge to establish itself as a strategic & successful pharmaceutical partner of choice in the MENA Region. NewBridge offers flexible partnership opportunities & best practices in the areas of commercial, regulatory, and medical affairs striving for quality performance & high standards of compliance that pharmaceutical companies look for in a partner to serve as an extension of their practices & values in local markets. NewBridge is well backed by strong institutional & corporate investors who provide us with the extensive life science network & diverse investment expertise needed to achieve our vision & build a platform of successful alliances in the region, and create value in an innovative business approach. This integrated strategy of regional expertise & strong global business network position NewBridge uniquely as an institutional one-stop-solution for our partners in its offering & as a preferred partner-of-choice for the biopharmaceutical & other healthcare companies seeking multi-country access in Middle East and Africa with its growing economies, yet complex regulations & access hurdles.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access